IL-1β, by binding to IL-1R, can stimulate the NF-κB pathway by a MyD88-dependent mechanism, triggering ubiquitin-proteasome system-mediated protein degradation and leading to decreased muscle mass, thus producing sarcopenia-osteoporosis systemically. The gene discussed is NFKB1; the disease is sarcopenia.